Published in Nat Med on August 01, 1998
MSCs for Prevention of MI-induced HF (PREVENT-TAHA) | NCT05043610
Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest (2001) 7.20
Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A (2001) 7.19
Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest (2001) 6.59
Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest (2005) 4.25
Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ Res (2013) 3.56
Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol (2006) 3.20
Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. J Clin Invest (2010) 3.09
Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci U S A (2003) 2.21
Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation. J Mol Cell Cardiol (2008) 2.16
Dissecting the molecular relationship among various cardiogenic progenitor cells. Circ Res (2013) 2.06
Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges. Eur Heart J (2011) 1.80
Cell therapy for the treatment of coronary heart disease: a critical appraisal. Nat Rev Cardiol (2010) 1.69
Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair. J Cell Biol (2000) 1.66
Heart regeneration in adult MRL mice. Proc Natl Acad Sci U S A (2001) 1.55
Colony-stimulating factor-1 transfection of myoblasts improves the repair of failing myocardium following autologous myoblast transplantation. Cardiovasc Res (2008) 1.54
In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor. J Am Heart Assoc (2012) 1.48
Mechanical preconditioning enables electrophysiologic coupling of skeletal myoblast cells to myocardium. J Thorac Cardiovasc Surg (2012) 1.44
The advancing field of cell-based therapy: insights and lessons from clinical trials. J Am Heart Assoc (2013) 1.40
Role of stem cells in cardiovascular biology. J Thromb Haemost (2011) 1.31
Biomimetic approach to cardiac tissue engineering. Philos Trans R Soc Lond B Biol Sci (2007) 1.31
Electrophysiological challenges of cell-based myocardial repair. Circulation (2009) 1.30
Imaging stem cells implanted in infarcted myocardium. J Am Coll Cardiol (2006) 1.28
Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration. PLoS One (2011) 1.22
Antioxidant levels represent a major determinant in the regenerative capacity of muscle stem cells. Mol Biol Cell (2008) 1.19
Anti-inflammation role for mesenchymal stem cells transplantation in myocardial infarction. Inflammation (2007) 1.18
Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease. Dis Model Mech (2009) 1.16
Human embryonic stem cells and cardiac repair. Transplant Rev (Orlando) (2008) 1.15
Lentiviral vectors bearing the cardiac promoter of the Na+-Ca2+ exchanger report cardiogenic differentiation in stem cells. Mol Ther (2008) 1.13
Biomaterial strategies for alleviation of myocardial infarction. J R Soc Interface (2011) 1.13
Adult-derived stem cells from the liver become myocytes in the heart in vivo. Am J Pathol (2001) 1.11
The bone marrow--cardiac axis of myocardial regeneration. Prog Cardiovasc Dis (2007) 1.10
Cardiac tissue engineering for replacement therapy. Heart Fail Rev (2003) 1.09
Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium. Proc Natl Acad Sci U S A (2004) 1.08
Injectable cardiac tissue engineering for the treatment of myocardial infarction. J Cell Mol Med (2010) 1.08
MR fluoroscopy in vascular and cardiac interventions (review). Int J Cardiovasc Imaging (2011) 1.04
Cellular cardiomyoplasty with autologous skeletal myoblasts for ischemic heart disease and heart failure. Curr Control Trials Cardiovasc Med (2001) 1.03
N-Cadherin: structure, function and importance in the formation of new intercalated disc-like cell contacts in cardiomyocytes. Heart Fail Rev (2000) 1.02
Challenges for heart disease stem cell therapy. Vasc Health Risk Manag (2012) 1.02
Cardiomyocyte formation by skeletal muscle-derived multi-myogenic stem cells after transplantation into infarcted myocardium. PLoS One (2008) 1.02
Atherosclerosis as a disease of failed endogenous repair. Front Biosci (2008) 1.00
Current perspectives on imaging cardiac stem cell therapy. J Nucl Med (2010) 1.00
Cardiac side population cells: moving toward the center stage in cardiac regeneration. Circ Res (2012) 0.98
Stem cells for heart cell therapies. Tissue Eng Part B Rev (2008) 0.98
Terminal differentiation is not a major determinant for the success of stem cell therapy - cross-talk between muscle-derived stem cells and host cells. Stem Cell Res Ther (2011) 0.97
Cardiac applications for human pluripotent stem cells. Curr Pharm Des (2009) 0.97
Retracted Transurethral ultrasonography-guided injection of adult autologous stem cells versus transurethral endoscopic injection of collagen in treatment of urinary incontinence. World J Urol (2007) 0.95
Skeletal myoblasts for cardiac repair. Regen Med (2010) 0.95
Mesenchymal stem cell: present challenges and prospective cellular cardiomyoplasty approaches for myocardial regeneration. Antioxid Redox Signal (2009) 0.94
Role of nitric oxide in matrix remodeling in diabetes and heart failure. Heart Fail Rev (2003) 0.93
Fabrication of skeletal muscle constructs by topographic activation of cell alignment. Biotechnol Bioeng (2009) 0.93
Programming and reprogramming a human heart cell. EMBO J (2015) 0.92
Activation of diverse signaling pathways by ex-vivo delivery of multiple cytokines for myocardial repair. Stem Cells Dev (2012) 0.92
Laser-patterned stem-cell bridges in a cardiac muscle model for on-chip electrical conductivity analyses. Lab Chip (2011) 0.92
Regenerating functional heart tissue for myocardial repair. Cell Mol Life Sci (2012) 0.92
Intrinsic ability of adult stem cell in skeletal muscle: an effective and replenishable resource to the establishment of pluripotent stem cells. Stem Cells Int (2013) 0.92
Stem cell therapy in heart diseases: a review of selected new perspectives, practical considerations and clinical applications. Curr Cardiol Rev (2011) 0.91
Development of bioartificial myocardium using stem cells and nanobiotechnology templates. Cardiol Res Pract (2010) 0.90
Multipotent (adult) and pluripotent stem cells for heart regeneration: what are the pros and cons? Stem Cell Res Ther (2013) 0.90
Stem cell therapy for cardiac dysfunction. Springerplus (2014) 0.90
Current stem cell delivery methods for myocardial repair. Biomed Res Int (2012) 0.89
The real estate of myoblast cardiac transplantation: negative remodeling is associated with location. J Heart Lung Transplant (2008) 0.89
Polymer transfected primary myoblasts mediated efficient gene expression and angiogenic proliferation. J Control Release (2009) 0.88
Organotypic heart slices for cell transplantation and physiological studies. Organogenesis (2009) 0.88
Myocardial scaffold-based cardiac tissue engineering: application of coordinated mechanical and electrical stimulations. Langmuir (2013) 0.88
Directed Fusion of Mesenchymal Stem Cells with Cardiomyocytes via VSV-G Facilitates Stem Cell Programming. Stem Cells Int (2012) 0.87
Metabolic modulation and cellular therapy of cardiac dysfunction and failure. J Cell Mol Med (2009) 0.87
Functional and histopathological improvement of the post-infarcted rat heart upon myoblast cell grafting and relaxin therapy. J Cell Mol Med (2008) 0.87
Human embryonic stem cells for myocardial regeneration. Heart Fail Rev (2003) 0.86
Clinical impact of combined transplantation of autologous skeletal myoblasts and bone marrow mononuclear cells in patients with severely deteriorated ischemic cardiomyopathy. Surg Today (2011) 0.85
Cardiac repair by embryonic stem-derived cells. Handb Exp Pharmacol (2006) 0.85
Signaling through the TRAIL receptor DR5/FADD pathway plays a role in the apoptosis associated with skeletal myoblast differentiation. Apoptosis (2006) 0.85
Adult progenitor cell transplantation influences contractile performance and calcium handling of recipient cardiomyocytes. Am J Physiol Heart Circ Physiol (2009) 0.85
Stem cell therapy for cardiac repair. J Cardiovasc Nurs (2009) 0.84
Stem cell differentiation: cardiac repair. Cells Tissues Organs (2007) 0.84
Cell tracking in cardiac repair: what to image and how to image. Eur Radiol (2011) 0.84
Strategies and methods to study sex differences in cardiovascular structure and function: a guide for basic scientists. Biol Sex Differ (2011) 0.84
Comparison of left ventricular electromechanical mapping and left ventricular angiography: defining practical standards for analysis of NOGA maps. Tex Heart Inst J (2003) 0.84
Stem cell therapy for ischemic heart disease. Antioxid Redox Signal (2010) 0.84
Cell-based approaches for cardiac repair. Ann N Y Acad Sci (2006) 0.84
Cell transplantation for cardiac regeneration: where do we stand? Neth Heart J (2008) 0.84
Stem cell stimulation of endogenous myocyte regeneration. Clin Sci (Lond) (2013) 0.83
Cell therapy with bone marrow cells for myocardial regeneration. Antioxid Redox Signal (2009) 0.83
Cell therapy in congestive heart failure. J Zhejiang Univ Sci B (2007) 0.83
Enhanced mesenchymal stem cell survival induced by GATA-4 overexpression is partially mediated by regulation of the miR-15 family. Int J Biochem Cell Biol (2013) 0.83
At a crossroad: cell therapy for cardiac repair. Circ Res (2013) 0.83
Myocardial regeneration of the failing heart. Heart Fail Rev (2013) 0.81
A plant-derived remedy for repair of infarcted heart. PLoS One (2009) 0.81
Clinical xenotransplantation of organs: why aren't we there yet? PLoS Med (2007) 0.81
Promises and pitfalls in cell replacement therapy for heart failure. Drug Discov Today Dis Mech (2010) 0.81
Translational findings from cardiovascular stem cell research. Trends Cardiovasc Med (2012) 0.81
Cardiovascular cell therapy and endogenous repair. Diabetes Obes Metab (2008) 0.80
Cardiac Regeneration and Stem Cells. Physiol Rev (2015) 0.80
Myoblast-based cell transplantation. Heart Fail Rev (2003) 0.79
Human bone marrow-derived mesenchymal stem cells transplanted into damaged rabbit heart to improve heart function. J Zhejiang Univ Sci B (2005) 0.79
Cardiovascular Stem Cells in Regenerative Medicine: Ready for Prime Time? Drug Discov Today Ther Strateg (2008) 0.79
Stem cell treatment of the heart: a review of its current status on the brink of clinical experimentation. Tex Heart Inst J (2005) 0.79
Functional ultrasound imaging for assessment of extracellular matrix scaffolds used for liver organoid formation. Biomaterials (2013) 0.79
Myocardial restoration: is it the cell or the architecture or both? Cardiol Res Pract (2012) 0.79
Discrepant Results of Experimental Human Mesenchymal Stromal Cell Therapy after Myocardial Infarction: Are Animal Models Robust Enough? PLoS One (2016) 0.79
Challenges in the translation of cardiovascular cell therapy. J Nucl Med (2010) 0.79
The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell (1996) 8.25
Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature (1996) 7.90
Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science (1998) 3.46
Referral patterns for coronary artery disease treatment: gender bias or good clinical judgment? Ann Intern Med (1992) 3.39
The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity (1997) 2.93
Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work. Circulation (1985) 2.65
Endothelial, cardiac muscle and skeletal muscle exhibit different viscous and elastic properties as determined by atomic force microscopy. J Biomech (2001) 2.64
Diagnosis of malaria in the field by fluorescence microscopy of QBC capillary tubes. Trans R Soc Trop Med Hyg (1992) 2.39
Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway. EMBO J (2001) 2.38
An Escherichia coli mutant defective in lipid export. J Biol Chem (2001) 2.32
Dislocation of type I membrane proteins from the ER to the cytosol is sensitive to changes in redox potential. J Cell Biol (1998) 2.16
Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells. Nat Med (1999) 2.08
Dictyostelium myosin I double mutants exhibit conditional defects in pinocytosis. J Cell Biol (1995) 2.01
Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine. Proc Natl Acad Sci U S A (1998) 1.93
Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. Circulation (1994) 1.91
Age-dependent acquired protection against Plasmodium falciparum in people having two years exposure to hyperendemic malaria. Am J Trop Med Hyg (1991) 1.87
Plasmodium falciparum-infected Anopheles stephensi inconsistently transmit malaria to humans. Am J Trop Med Hyg (1990) 1.85
Tomographic 3D reconstruction of quick-frozen, Ca2+-activated contracting insect flight muscle. Cell (1999) 1.85
Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells. J Exp Med (1998) 1.81
Life and death of an intracellular pathogen: Francisella tularensis and the macrophage. Immunol Ser (1994) 1.73
Intensive Therapy for Early Syphilis. Br Med J (1943) 1.71
Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine. Proc Natl Acad Sci U S A (2001) 1.63
Intraoperative measurement of parathyroid hormone in the surgical management of hyperparathyroidism. Surgery (1988) 1.61
Multiple regulatory events influence human cytomegalovirus DNA polymerase (UL54) expression during viral infection. J Virol (1996) 1.60
Preservation of myocardial beta-adrenergic receptor signaling delays the development of heart failure after myocardial infarction. Proc Natl Acad Sci U S A (2000) 1.57
Ultrastructural study of guinea pig tracheal smooth muscle and its innervation. Can J Physiol Pharmacol (1980) 1.57
Periampullary malignancy in Gardner's syndrome. Ann Surg (1977) 1.53
Restoration of beta-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer. Proc Natl Acad Sci U S A (1997) 1.51
The HCMV gene products US11 and US2 differ in their ability to attack allelic forms of murine major histocompatibility complex (MHC) class I heavy chains. J Exp Med (1997) 1.51
Phosphorylation-dependent power output of transgenic flies: an integrated study. Biophys J (1997) 1.50
Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia. Clin Infect Dis (1999) 1.49
Three-dimensional reconstruction of rigor insect flight muscle from tilted thin sections. Nature (1984) 1.48
Capillary density of skeletal muscle: a contributing mechanism for exercise intolerance in class II-III chronic heart failure independent of other peripheral alterations. J Am Coll Cardiol (1999) 1.47
Expression and analysis of the human cytomegalovirus UL80-encoded protease: identification of autoproteolytic sites. J Virol (1993) 1.47
Steady-state free precession magnetic resonance imaging of the heart: comparison with segmented k-space gradient-echo imaging. J Magn Reson Imaging (2001) 1.47
Why do individuals not lose more weight from an exercise intervention at a defined dose? An energy balance analysis. Obes Rev (2012) 1.47
Comparison of balloon valvuloplasty with operative treatment for mitral stenosis. Ann Thorac Surg (1993) 1.46
Rigor crossbridge structure in tilted single filament layers and flared-X formations from insect flight muscle. J Mol Biol (1985) 1.46
In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction. Circulation (2001) 1.45
Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence. Science (1991) 1.43
Molecular genetics of Drosophila alpha-actinin: mutant alleles disrupt Z disc integrity and muscle insertions. J Cell Biol (1990) 1.41
Randomized, parallel placebo-controlled trial of primaquine for malaria prophylaxis in Papua, Indonesia. Clin Infect Dis (2001) 1.40
A phase I evaluation of the quinazoline antifolate thymidylate synthase inhibitor, N10-propargyl-5,8-dideazafolic acid, CB3717. J Clin Oncol (1986) 1.40
The human cytomegalovirus UL97 protein is phosphorylated and a component of virions. Virology (1997) 1.40
X-ray diffraction indicates that active cross-bridges bind to actin target zones in insect flight muscle. Biophys J (1998) 1.38
Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am J Respir Crit Care Med (2001) 1.37
A potent antitumour quinazoline inhibitor of thymidylate synthetase: synthesis, biological properties and therapeutic results in mice. Eur J Cancer (1981) 1.35
Structure and paramyosin content of tarantula thick filaments. J Cell Biol (1983) 1.31
Induction of chimerism in rhesus macaques through stem cell transplant and costimulation blockade-based immunosuppression. Am J Transplant (2007) 1.30
Novel class of thiourea compounds that inhibit herpes simplex virus type 1 DNA cleavage and encapsidation: resistance maps to the UL6 gene. J Virol (2000) 1.30
Predictors of cognitive decline after cardiac operation. Ann Thorac Surg (1995) 1.28
Disruption of a dynamin homologue affects endocytosis, organelle morphology, and cytokinesis in Dictyostelium discoideum. Mol Biol Cell (1999) 1.27
Age-specific prevalence of Plasmodium falciparum among six populations with limited histories of exposure to endemic malaria. Am J Trop Med Hyg (1993) 1.26
Fibronectin and glial fibrillary acidic protein expression in normal human brain and anaplastic human gliomas. Cancer Res (1982) 1.25
Cine MRI using steady state free precession in the radial long axis orientation is a fast accurate method for obtaining volumetric data of the left ventricle. J Magn Reson Imaging (2001) 1.24
Use of recombinant virus to assess human cytomegalovirus early and late promoters in the context of the viral genome. J Virol (1994) 1.24
Chloroquine/doxycycline combination versus chloroquine alone, and doxycycline alone for the treatment of Plasmodium falciparum and Plasmodium vivax malaria in northeastern Irian Jaya, Indonesia. Am J Trop Med Hyg (2001) 1.22
Long-term outcome after biologic versus mechanical aortic valve replacement in 841 patients. J Thorac Cardiovasc Surg (1999) 1.20
Cellular cardiomyoplasty improves diastolic properties of injured heart. J Surg Res (1999) 1.19
Identification of a muscle-specific enhancer within the 5'-flanking region of the human myoglobin gene. J Biol Chem (1989) 1.19
Immunohistochemical detection of factor VIII/von Willebrand factor in hyperplastic endothelial cells in glioblastoma multiforme and mixed glioma-sarcoma. J Neuropathol Exp Neurol (1982) 1.18
Studies of the androgen receptor in dispersed fibroblasts: investigation of patients with androgen insensitivity. Clin Endocrinol (Oxf) (1984) 1.14
E1A-mediated inhibition of myogenesis correlates with a direct physical interaction of E1A12S and basic helix-loop-helix proteins. Mol Cell Biol (1993) 1.13
Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts. Cell Transplant (2000) 1.13
Protection of mice against Plasmodium yoelii sporozoite challenge with P. yoelii merozoite surface protein 1 DNA vaccines. Infect Immun (1998) 1.12
Results of valve replacement with mechanical and biological prostheses in chronic renal dialysis patients. Ann Thorac Surg (1997) 1.12
Evidence for specific suppression of gametocytemia by Plasmodium falciparum in residents of hyperendemic Irian Jaya. Am J Trop Med Hyg (1991) 1.12
Intracoronary adenovirus-mediated delivery and overexpression of the beta(2)-adrenergic receptor in the heart : prospects for molecular ventricular assistance. Circulation (2000) 1.12
Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary beta2-adrenergic receptor gene delivery. J Clin Invest (1999) 1.12
First report of the Port Access International Registry. Ann Thorac Surg (1999) 1.11
Inhibition of caspases inhibits the release of apoptotic bodies: Bcl-2 inhibits the initiation of formation of apoptotic bodies in chemotherapeutic agent-induced apoptosis. J Cell Biol (1999) 1.10
Specificity and sensitivity of immunohistochemical detection of factor VIII/von Willebrand factor antigen in formalin-fixed paraffin-embedded tissue. J Histochem Cytochem (1982) 1.10
Translational regulation of the human cytomegalovirus pp28 (UL99) late gene. J Virol (1997) 1.10
Control of human airway smooth muscle: in vitro studies. J Appl Physiol Respir Environ Exerc Physiol (1982) 1.10
A peptide derived from the non-receptor-binding region of urokinase plasminogen activator inhibits glioblastoma growth and angiogenesis in vivo in combination with cisplatin. Proc Natl Acad Sci U S A (2000) 1.09
The infectivity of Plasmodium yoelii in different strains of mice. J Parasitol (2003) 1.08
Exercise-induced angiogenesis-related growth and transcription factors in skeletal muscle, and their modification in muscle pathology. Front Biosci (2001) 1.07
Mitochondrial biogenesis in striated muscles: rapid induction of citrate synthase mRNA by nerve stimulation. Am J Physiol (1991) 1.07
Induction and maintenance of increased VEGF protein by chronic motor nerve stimulation in skeletal muscle. Am J Physiol (1998) 1.07
Serum lipids in the GENECARD study of coronary artery disease identify quantitative trait loci and phenotypic subsets on chromosomes 3q and 5q. Ann Hum Genet (2006) 1.06
Electron tomography of insect flight muscle in rigor and AMPPNP at 23 degrees C. J Mol Biol (1996) 1.06
Hybridization between a repeated region of herpes simplex virus type 1 DNA containing the sequence [GGC]n and heterodisperse cellular DNA and RNA. Virus Res (1987) 1.05
The stenosis ratio: a new tool for the diagnosis of degenerative spinal stenosis. Int J Surg Investig (1999) 1.05
Altered expression of myosin heavy chain in human skeletal muscle in chronic heart failure. Med Sci Sports Exerc (1997) 1.05
Molecular beta-adrenergic signaling abnormalities in failing rabbit hearts after infarction. Am J Physiol (1999) 1.04
Molecular genetic analysis of myoC, a Dictyostelium myosin I. J Cell Sci (1995) 1.04
L-649,923, sodium (beta S*, gamma R*)-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propylthio)- gamma-hydroxy-beta-methylbenzenebutanoate, a selective, orally active leukotriene receptor antagonist. Can J Physiol Pharmacol (1986) 1.04
Orientation and length of mammalian skeletal myocytes in response to a unidirectional stretch. Cell Tissue Res (2000) 1.03
Pharmacological study of the contractile activity of leukotriene C4 and D4 on isolated human airway smooth muscle. Can J Physiol Pharmacol (1982) 1.02
Binding of myosin subfragment 1 to glycerinated insect flight muscle in the rigor state. Biophys J (1985) 1.02
CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein. Infect Immun (1999) 1.01
Hybridization of herpes simplex virus DNA and human ribosomal DNA and RNA. Virology (1985) 1.01
A longitudinal study of an endemic disease in its wildlife reservoir: cowpox and wild rodents. Epidemiol Infect (2000) 1.01
A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo. FASEB J (2000) 1.01
A method for perfusion of the leg during cardiopulmonary bypass via femoral cannulation. Ann Thorac Surg (1998) 1.00
Developmental changes in the ultrastructure and sarcomere shortening of the isolated rabbit ventricular myocyte. Circ Res (1987) 1.00
Increased expression of fibroblast growth factors in a rabbit skeletal muscle model of exercise conditioning. J Clin Invest (1990) 0.99